Group issues guidelines on continuous glucose monitoring

10/12/2011 | Medscape (free registration)

The Endocrine Society has released guidelines on continuous glucose monitoring in diabetes patients, which the association describes as a beneficial tool to maintain ideal levels of blood glucose. The guidelines, published in the Journal of Clinical Endocrinology and Metabolism, recommend that real time-CGM alone should not be used for adults in intensive care, and that young patients with type 1 diabetes whose glycosylated hemoglobin levels were higher or lower than 7% should use RT-CGM with approved devices.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT